SIRS and multi-organ dysfunction after burn injury

Overview¶

A major burn does more than destroy skin. Thermal injury of more than 20% of body surface area produces a systemic state that resembles severe sepsis or septic shock, with the same hemodynamic and inflammatory signatures ^[3]. Burns were once excluded from the surgical literature on multiple organ failure, but burn patients manifest organ failure in a manner similar to other surgical populations, and the syndrome has become central to burn critical care ^[17]. The practical consequence is stark: burn patients, by definition, already meet the clinical picture of a systemic inflammatory response ^[9].

The systemic inflammatory response syndrome (SIRS) is the body's generalized reaction to a major insult, presenting with hypotension, tachypnea, temperature derangement, leukocytosis, and depressed myocardial contractility ^[18]. When that response is severe and sustained, it progresses to multiple organ failure (MOF), classically defined as the successive failure of respiratory, hepatic, renal, myocardial, gastrointestinal, or neurological systems in a patient who is hyperdynamic and hypermetabolic ^[19]. The original surgical description fixed the threshold at failure of two or more organ systems ^[20]. This topic covers how that response is generated, how it is measured, what drives it, and why it kills.

Epidemiology¶

Organ dysfunction is common after major burns and is consistently linked to poor outcomes ^[7]. Reported incidence varies widely with the cohort and the definition used. In a contemporary adult burn population, the incidence of multi-organ dysfunction was 63% and frank multi-organ failure 37% ^[21]. Older series in severely burned patients reported MOF in roughly 28% of those at risk ^[22,23]. Expressed against all admissions rather than only the severely injured, the rate falls sharply, on the order of 2% to 3% ^[24], reflecting how strongly the syndrome concentrates in the most extensively burned.

Burn size, age, and inhalation injury are the dominant and recurring risk factors. Severe MOD and severe sepsis or septic shock both track with burn size, advancing age, and male sex ^[23]. Full-thickness burn size, age, and inhalation injury were independently associated with MOD, sepsis, and death in a large single-center analysis ^[4]. The same triad of TBSA, age, and inhalation injury reappeared as significant predictors of MOF in a separate modern cohort ^[5]. Burn surface area in particular emerges as the most influential factor for SIRS incidence ^[25]. Inhalation injury carries outsized weight: in one national series, postburn MOF occurred in only 2.38% of all burn victims, but in those with inhalation injury the incidence reached 20.77%, accounting for roughly two-thirds of all postburn MOF ^[24].

There are recognizable burn-size thresholds beyond which these complications cluster. In children, the cutoff burn size for mortality, sepsis, infection, and multiple organ failure was approximately 60% TBSA; in adults the corresponding cutoff was lower, at approximately 40% TBSA ^[26]. The incidence of SIRS and MODS was three times higher in patients with more than 30% TBSA ^[27]. Genetic susceptibility also shapes risk: carriage of the TLR4 +896 and TNF-alpha -308 polymorphisms was significantly associated with an increased risk of severe sepsis following burn trauma ^[28]. Among the discrete organ failures, acute kidney injury alone has a pooled incidence near 40% in burn populations ^[29], and intra-abdominal hypertension affects roughly half of patients with severe burns ^[29,30,31]. The burden is not evenly distributed across patients: sepsis prevalence in burn cohorts has been reported between 8% and 42.5%, substantially higher than in general trauma populations ^[32].

Pathophysiology¶

The systemic response begins at the wound. The two loci of injury are the wound itself, where macrophages activate and produce proinflammatory mediators, and the microcirculation, where endothelial cells and blood elements activate and a capillary leak develops ^[33]. Sepsis, hemorrhage, ischemia-reperfusion, and soft-tissue trauma all share the ability to activate macrophages and produce proinflammatory cytokines that initiate SIRS, with the cytokine system functioning as a final common pathway for noxious stimuli ^[33]. After burn injury, a massive local and systemic inflammatory response is induced, with a prolonged increase in complement levels in both the burn wound and the blood and an increased inflammatory-cell infiltrate ^[34]. The MOF syndrome is understood as a generalized inflammatory reaction to tissue injury involving a cascade of mediators of macrophage and lymphocyte origin ^[19].

Sterile danger signals are central to the burn version of this cascade. Damage-associated molecular patterns (DAMPs), including mitochondrial DNA released after tissue injury, play a crucial role in driving the inflammation that follows a burn ^[35]. Among soluble mediators, interleukin-6 has emerged as a marker and potential driver of lethal sepsis after major thermal trauma ^[36]. High-mobility-group box-1 (HMGB1) is elevated on the first post-burn day and runs significantly higher in patients who develop MODS than in those who do not ^[37]. The complement system, an immediate host-defense mechanism after burn and trauma, becomes detrimental when massively activated and can contribute to organ failure ^[38]; uncontrolled complement activation drives disease progression rather than supporting healing ^[38,39]. Oxygen free radicals likewise play an important role in the genesis and development of postburn MOF ^[40]. Newer mechanistic work continues to refine these pathways, with microvesicle particles and platelet-activating factor proposed as contributors to the systemic effects of extensive burns ^[41].

A failing gut barrier amplifies the response. Increased gut permeability after burn injury has been implicated in the predisposition to sepsis and multiple organ failure ^[42]. The gut microbiota and luminal environment are severely altered after major burns, and these abnormal gut conditions may influence the systemic inflammatory response and multiple organ dysfunction ^[43]. Serial experimental and clinical studies have linked the ischemia-reperfusion injury of severe shock, sepsis, and inhalation injury to the SIRS that initiates postburn MODS ^[44]. Early MOF developing without an identifiable infectious focus has been attributed to endotoxemia originating from the patient's own intestine ^[45]. This connects to the hypermetabolic engine of the burn course: severe burn trauma drives a persistent inflammatory state with an ongoing hypermetabolic and catabolic burden ^[46], and nonsurvivors show a markedly exaggerated hypermetabolic response associated with greater organ dysfunction and sepsis than survivors ^[47].

The clinical trajectory is best captured by the two-hit model. The increase in plasma endotoxin can act as a trigger that causes a recurrence of systemic inflammation and the cardiac and multi-organ changes that follow ^[48]; a second insult such as infection further amplifies the process into a vicious cycle of inflammation, tissue damage, and immunosuppression ^[48,49]. The large mass of devitalized tissue, together with invasive infection, frequently constitutes that second hit ^[6]. At the organ level, the mechanism is concrete: induction of inducible nitric oxide synthase by inflammatory cytokines produces a marked depression of myocyte contractile responsiveness, explaining the cardiac depression of SIRS ^[18]. When complement and IL-6 levels are tracked, they correlate well with injury severity and the subsequent development of infection ^[50].

Assessment¶

There is no burn-specific biomarker or score that reliably separates inflammation from infection, and this is the central diagnostic problem of the field. The Sequential Organ Failure Assessment (SOFA) score is useful for quantifying organ dysfunction in burn patients ^[51], and SOFA values at admission and over the first days are independently associated with mortality ^[51]. In thermally injured patients, organ failure scores correlated with outcome more closely than APACHE II scores in a prospective study ^[17].

Conventional sepsis criteria fail in burns precisely because the burn itself produces the same signs. SIRS criteria were not discriminative in one burn cohort, where 98% of subjects met criteria ^[8]. When formal definitions were compared head to head, the ABA criteria and the Sepsis-3 definition provided no advantage over SIRS criteria for the early diagnosis of sepsis after burn injury ^[52]; in another series Sepsis-3 was the most predictive, followed by ABA and Mann-Salinas criteria, though none reached the accuracy of a diagnostic standard ^[52,53]. Burn-specific modification helps with specificity at the cost of sensitivity: the burn-specific ABA SIRS criteria reached 74.2% specificity versus 29.9% for generic SIRS, but sensitivity fell from 100% to 58% ^[54].

Biomarkers add discriminating power but no single test is definitive. The combined determination of macrophage migration inhibitory factor and procalcitonin has been proposed to discriminate post-burn inflammation from SIRS or sepsis with lethal outcome ^[55]. Early coagulation derangement is informative: severe thermal injury is associated with early activation of the coagulation cascade, disseminated intravascular coagulation, organ failure, and increased mortality ^[56]. Admission hypoalbuminemia at or below 30 g/L is associated with a two-fold increase in organ dysfunction measured by SOFA ^[57]. Perioperative lactate has prognostic value, with post-operative day 3 lactate significantly associated with clinical deterioration ^[58].

Management¶

Treatment of post-burn SIRS and MODS is supportive and source-directed; there is no specific therapy that reverses the established syndrome. Once a patient enters the organ failure syndrome, most treatment modalities, including ventilation, antibiotics, nutrition, and surgery, become progressively ineffective ^[59]. This places the emphasis on prevention and early intervention. The treatment strategy is framed as blunting the first hit, preventing the second hit, and supplementing with visceral and nutritional support ^[6].

Adequate burn-shock resuscitation comes first, and its quality shapes downstream organ function. Comprehensive measures for severe post-burn sepsis are described as rapid and adequate fluid resuscitation, early feeding, effective infection control, early escharectomy, and reinforcement of organ support ^[10]. Source control of infected tissue is repeatedly identified as pivotal: early, aggressive, and thorough surgical excision of invasive burn-infected tissue with wound closure plays a crucial role in outcome ^[10,60]. At the same time, over-resuscitation is harmful; sources caution against giving excessive crystalloid volume to these patients ^[61]. Glycemic control has supportive evidence: intensive insulin therapy significantly decreased the incidence of infections and sepsis and improved organ function as reflected in serum markers and Denver-2 scores in severely burned children ^[62]. Nutritional and rehabilitative optimization is recommended to improve outcomes in critically ill burn patients ^[63]. For established renal failure or refractory disease, organ-support modalities such as continuous renal replacement therapy and, in highly selected cases at specialized centers, extracorporeal membrane oxygenation are used, with sepsis treatment as the focus when CRRT is required ^[11,64].

The history of mediator-directed therapy is a history of disappointment, which is why no anti-inflammatory agent has entered routine burn care. Five percent albumin given over the first two weeks did not decrease the burden of MODS in adult burn patients ^[65]. Hemoadsorption with the CytoSorb cartridge did not produce significant systemic reductions in measured cytokines or myoglobin despite efficient transmembrane clearance ^[66]. Diagnosis itself is treated as a clinical act: one validation study concluded that sepsis is best assessed, diagnosed, and documented prospectively by the burn team rather than by retrospective application of criteria ^[53].

Complications¶

The systemic response expresses itself as discrete organ failures, and SIRS frequently progresses to ARDS, disseminated intravascular coagulation, renal failure, shock, and multi-organ dysfunction ^[67]. The organs do not fail uniformly. In one classic analysis the most frequently affected organ was the lung, followed by the heart, kidney, liver, and the clotting system ^[45]; a contemporary major-burn cohort found hematologic failure most common at 68.6%, followed by respiratory failure at 48.9% ^[7,45].

Respiratory failure is tightly bound to inhalation injury. Patients with inhalation injury had a 73% incidence of respiratory failure and a 20% incidence of adult respiratory distress syndrome, versus 5% and 2% respectively in those without inhalation injury ^[13]. Acute kidney injury is among the most morbid complications, with incidence and mortality reported as high as 30% and 80% respectively, and late AKI is typically driven by sepsis, multi-organ failure, and nephrotoxic drugs ^[12]. Abdominal complications form a distinct and lethal cluster: secondary abdominal compartment syndrome is a lethal complication of burn-shock resuscitation even after abdominal decompression ^[14], and the development of secondary ACS is associated with multi-organ dysfunction ^[14,68]. Hepatic dysfunction is common early and prognostically important, with persistent and advanced hepatic dysfunction associated with mortality ^[69]. Cardiac manifestations have risen as patients survive longer, with endocarditis and the cardiac manifestations of multiple organ failure increasing as length of survival extends ^[70]. Even the peripheral nervous system is affected, with axonal sensorimotor polyneuropathies reported as complications of sepsis and MOF in severely burned patients ^[71].

Outcomes¶

MODS and sepsis are the leading causes of late death after burn injury. A six-year review of burn-unit deaths found multi-organ failure to be the most common cause, accounting for 67%, frequently in the clinical absence of uncontrolled infection at the time of death ^[1]. In a Dutch national series, MOF was the most common cause of late mortality, responsible for 38.3% of deaths occurring beyond 48 hours ^[2]. Over a 20-year pediatric experience, the leading causes of death were sepsis at 47%, respiratory failure at 29%, anoxic brain injury at 16%, and shock at 8%; the proportion due to sepsis rose from 35% to 54% across the two decades, with a significant increase in antibiotic-resistant organisms ^[72]. The temporal pattern matters for prognosis and trial design: deaths concentrate within 72 hours of injury and decline thereafter without a later mortality peak ^[73].

Mortality climbs steeply with the number of failed systems. Patients with three or more organ-system failures have very high mortality rates ^[74]. Splanchnic ischemia and gut mucosal injury are recognized as central to the sepsis-MOF axis, and the survival of critically ill patients with multi-organ failure had not improved significantly across the first two decades after the syndrome was described ^[75]. There is room for optimism on the resuscitation and supportive side: a single-center series documented a significant improvement in survival of more recent patients, attributed to better early treatment of inhalation injury, sepsis, and multi-organ failure ^[76]. The original surgical description recorded a mean duration of multiple organ failure of 30.5 days, underscoring the prolonged, resource-intensive course these patients face ^[20].

Special Considerations¶

Age sits at both extremes of vulnerability. Elderly burn patients show substantially different responses to burns, with increased morbidity and mortality, more premorbid conditions, and longer hospital stays ^[77]. Notably, one analysis found no higher incidence of infection or sepsis in the elderly but a significantly increased incidence of multi-organ failure, linked to a delayed and dysregulated hypermetabolic and inflammatory response ^[77]. Comorbidities and age over 65 are established leading risk factors for the persistent inflammation, immunosuppression, and catabolism syndrome (PICS), a chronic critical-illness phenotype of prolonged organ dysfunction ^[15].

Children are not small adults in this regard. A significant number sustain burns greater than 15% TBSA, the threshold at which SIRS initiates ^[78]. In U.S. pediatric ICUs, burn-injured children carry a substantial burden of organ failure, morbidity, and mortality ^[16]. The persistent inflammation phenotype is also seen in children, where PIICS occurred in approximately one in six pediatric burn patients and was driven by inhalation injury and TBSA ^[79]. Electrical injury carries its own profile: in high-voltage electrical burns mortality was 18%, most often following multiple organ failure ^[80].

Controversies and Evidence Gaps¶

The deepest gap is mechanistic. The exact mechanisms underlying the multi-organ dysfunction and immune deficits of extensive burns remain unclear, and this knowledge gap has directly impaired the development of therapy ^[41]. The therapeutic record reflects that gap: nearly all strategies aimed specifically at neutralizing inflammatory mediators or cytokines to control sepsis have failed in clinical trials, and the treatment of established organ failure is usually unsuccessful ^[6].

Diagnosis is the second unresolved front. The early diagnosis of sepsis in severely burned patients is difficult, and both Sepsis-1 and Sepsis-3 guidelines have been found inappropriate for diagnosing sepsis in patients with severe burn injuries ^[81]. No single criterion has the accuracy to serve as a diagnostic standard in this population ^[53], and the usefulness of the ABA criteria is limited to the day before a positive blood culture ^[8,53]. Whether newer organ-specific scoring or model-based approaches resolve this remains an active question, with discriminative power of organ-specific SOFA assessment in burn sepsis under current investigation ^[82]. Evidence for entire intervention classes is still thin: a recent meta-analysis concluded that the evidence on severe sepsis, septic shock, and MODS incidence with omega-3 supplementation was insufficient and inconclusive ^[83]. Burn patients face genuine diagnostic challenges distinguishing sepsis from systemic inflammation under Sepsis-3 criteria, and the field continues to search for burn-specific markers ^[82].

References¶

[1] Sheridan RL, Ryan CM, Yin LM, Hurley J, Tompkins RG "Death in the burn unit: sterile multiple organ failure." Burns : journal of the International Society for Burn Injuries 1998. PMID: 9688194 ↩

[2] Dokter J, et al. "Mortality and causes of death of Dutch burn patients during the period 2006-2011." Burns : journal of the International Society for Burn Injuries 2015. PMID: 25481974 ↩

[3] Fuchs PCh, Groger A, Bozkurt A, Johnen D, Wolter T, Pallua N "Cortisol in severely burned patients: investigations on disturbance of the hypothalamic-pituitary-adrenal axis." Shock (Augusta, Ga.) 2007. PMID: 18092382 ↩

[4] Fitzwater J, Purdue GF, Hunt JL, O'Keefe GE "The risk factors and time course of sepsis and organ dysfunction after burn trauma." The Journal of trauma 2003. PMID: 12777910 ↩

[5] Ogura A, et al. "Associations between clinical characteristics and the development of multiple organ failure after severe burns in adult patients." Burns : journal of the International Society for Burn Injuries 2019. PMID: 31690472 ↩

[6] Sheng Z "Prevention of multiple organ dysfunction syndrome in patients with extensive deep burns." Chinese journal of traumatology = Zhonghua chuang shang za zhi 2002. PMID: 12162895 ↩

[7] Feng JY, et al. "Predictors of Early Onset Multiple Organ Dysfunction in Major Burn Patients with Ventilator Support: Experience from A Mass Casualty Explosion." Scientific reports 2018. PMID: 30026512 ↩

[8] Mann-Salinas EA, et al. "Novel predictors of sepsis outperform the American Burn Association sepsis criteria in the burn intensive care unit patient." Journal of burn care & research : official publication of the American Burn Association 2013. PMID: 23135212 ↩

[9] Greenhalgh DG, et al. "American Burn Association consensus conference to define sepsis and infection in burns." Journal of burn care & research : official publication of the American Burn Association 2007. PMID: 17925660 ↩

[10] Yao YM, Sheng ZY, Chai JK "[The pathogenesis and management of severe sepsis after burns]." Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns 2008. PMID: 19103010 ↩

[11] Yoon J, et al. "Analysis of prognostic factors for acute kidney injury with continuous renal replacement therapy in severely burned patients." Burns : journal of the International Society for Burn Injuries 2017. PMID: 28420565 ↩

[12] Clark A, et al. "Acute kidney injury after burn." Burns : journal of the International Society for Burn Injuries 2017. PMID: 28412129 ↩

[13] Hollingsed TC, Saffle JR, Barton RG, Craft WB, Morris SE "Etiology and consequences of respiratory failure in thermally injured patients." American journal of surgery 1993. PMID: 8273836 ↩

[14] Oda J, et al. "Acute lung injury and multiple organ dysfunction syndrome secondary to intra-abdominal hypertension and abdominal decompression in extensively burned patients." The Journal of trauma 2007. PMID: 17563650 ↩

[15] Rosenthal MD, Moore FA "Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure." Journal of advanced nutritional and human metabolism 2015. PMID: 26086042 ↩

[16] McCrory MC, Woodruff AG, Saha AK, Halvorson EE, Critcher BM, Holmes JH "Characteristics of Burn-Injured Children in 117 U.S. PICUs (2009-2017): A Retrospective Virtual Pediatric Systems Database Study." Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2021. PMID: 33689253 ↩

[17] Saffle JR, Sullivan JJ, Tuohig GM, Larson CM "Multiple organ failure in patients with thermal injury." Critical care medicine 1993. PMID: 8222683 ↩

[18] Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW "Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes." Journal of molecular and cellular cardiology 1995. PMID: 7539082 ↩

[19] Charbonneau P, Suisse A "[Syndrome of multiple organ failure]." La Revue du praticien 1990. PMID: 2263856 ↩

[20] Eiseman B, Beart R, Norton L "Multiple organ failure." Surgery, gynecology & obstetrics 1977. PMID: 841449 ↩

[21] Belba MK, Petrela EY, Belba AG "Epidemiology and outcome analysis of sepsis and organ dysfunction/failure after burns." Burns : journal of the International Society for Burn Injuries 2017. PMID: 28545914 ↩

[22] Huang YS, Li A, Yang ZC "Clinical studies on postburn multiple organ failure: its aetiological factors and monitoring." Burns : journal of the International Society for Burn Injuries 1992. PMID: 1558669 ↩

[23] Cumming J, Purdue GF, Hunt JL, O'Keefe GE "Objective estimates of the incidence and consequences of multiple organ dysfunction and sepsis after burn trauma." The Journal of trauma 2001. PMID: 11265031 ↩

[24] Huang Y, Yang Z, Li A "[Multiple organ failure in burn patients combined with inhalation injury]." Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns 1996. PMID: 9387470 ↩

[25] Aldy MHS, Handriani I, Magda RH "Correlation of risk factors with systemic inflammatory response syndrome in burn patients at the Burn Center of Dr Soetomo General Hospital, Surabaya, Indonesia." The Medical journal of Malaysia 2024. PMID: 38817054 ↩

[26] Jeschke MG, et al. "Morbidity and survival probability in burn patients in modern burn care." Critical care medicine 2015. PMID: 25559438 ↩

[27] Dehne MG, Sablotzki A, Hoffmann A, Mühling J, Dietrich FE, Hempelmann G "Alterations of acute phase reaction and cytokine production in patients following severe burn injury." Burns : journal of the International Society for Burn Injuries 2002. PMID: 12220910 ↩

[28] Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW "TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury." Journal of medical genetics 2004. PMID: 15520404 ↩

[29] Wu G, Xiao Y, Wang C, Hong X, Sun Y, Ma B, Wang G, Xia Z "Risk Factors for Acute Kidney Injury in Patients With Burn Injury: A Meta-Analysis and Systematic Review." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 27617407 ↩

[30] Mbiine R, Alenyo R, Kobusingye O, Kuteesa J, Nakanwagi C, Lekuya HM, Kituuka O, Galukande M "Intra-abdominal hypertension in severe burns: prevalence, incidence and mortality in a sub-Saharan African hospital." International journal of burns and trauma 2017. PMID: 29119060 ↩

[31] Strang SG, Breederveld RS, Cleffken BI, Verhofstad MHJ, Van Waes OJF, Van Lieshout EMM "Prevalence of intra-abdominal hypertension and markers for associated complications among severe burn patients: a multicenter prospective cohort study (BURNIAH study)." European journal of trauma and emergency surgery : official publication of the European Trauma Society 2022. PMID: 33721051 ↩

[32] Mann EA, Baun MM, Meininger JC, Wade CE "Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature." Shock (Augusta, Ga.) 2012. PMID: 21941222 ↩

[33] Harris BH, Gelfand JA "The immune response to trauma." Seminars in pediatric surgery 1995. PMID: 7633853 ↩

[34] Korkmaz HI, Ulrich MMW, van Wieringen WN, Vlig M, Emmens RW, Meyer KW, Sinnige P, Krijnen PAJ "The Local and Systemic Inflammatory Response in a Pig Burn Wound Model With a Pivotal Role for Complement." Journal of burn care & research : official publication of the American Burn Association 2017. PMID: 28447971 ↩

[35] Liu R, Xu F, Bi S, Zhao X, Jia B, Cen Y "Mitochondrial DNA-Induced Inflammatory Responses and Lung Injury in Thermal Injury Murine Model: Protective Effect of Cyclosporine-A." Journal of burn care & research : official publication of the American Burn Association 2019. PMID: 30926991 ↩

[36] Schlüter B, König B, Bergmann U, Müller FE, König W "Interleukin 6--a potential mediator of lethal sepsis after major thermal trauma: evidence for increased IL-6 production by peripheral blood mononuclear cells." The Journal of trauma 1991. PMID: 1749040 ↩

[37] Dong N, et al. "[Change in T cell-mediated immunity and its relationship with high mobility group box-1 protein levels in extensively burned patients]." Zhonghua wai ke za zhi [Chinese journal of surgery] 2008. PMID: 18953932 ↩

[38] Gallinaro R, Cheadle WG, Applegate K, Polk HC "The role of the complement system in trauma and infection." Surgery, gynecology & obstetrics 1992. PMID: 1570624 ↩

[39] Mannes M, Schmidt CQ, Nilsson B, Ekdahl KN, Huber-Lang M "Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis." Seminars in immunopathology 2021. PMID: 34191093 ↩

[40] Yang ZC "[Clinical study of the pathogeneses of multiple organ failure after burns]." Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns 1992. PMID: 1596797 ↩

[41] Parackal AV, et al. "Evidence for microvesicle particles and platelet-activating factor as effectors for systemic effects of thermal burn injury." Frontiers in immunology 2026. PMID: 41816325 ↩

[42] Messick WJ, Koruda M, Meyer A, Zimmerman K "Differential changes in intestinal permeability following burn injury." The Journal of trauma 1994. PMID: 7511707 ↩

[43] Shimizu K, Ogura H, Asahara T, Nomoto K, Matsushima A, Hayakawa K, Ikegawa H, Tasaki O "Gut microbiota and environment in patients with major burns – a preliminary report." Burns : journal of the International Society for Burn Injuries 2015. PMID: 25465986 ↩

[44] Huang YS, Yang ZC, Liu XS, Chen FM, He BB, Li A, Crowther RS "Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome (MODS) in severe burns." Burns : journal of the International Society for Burn Injuries 1998. PMID: 9915670 ↩

[45] Aikawa N, et al. "Clinical analysis of multiple organ failure in burned patients." Burns, including thermal injury 1987. PMID: 3580933 ↩

[46] Orman MA, Ierapetritou MG, Berthiaume F, Androulakis IP "The dynamics of the early inflammatory response in double-hit burn and sepsis animal models." Cytokine 2011. PMID: 21824784 ↩

[47] Jeschke MG, Gauglitz GG, Finnerty CC, Kraft R, Mlcak RP, Herndon DN "Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories." Annals of surgery 2014. PMID: 23579577 ↩

[48] Ulrich D, Noah EM, Pallua N "[Plasma endotoxin, procalcitonin, C-reactive protein, and organ functions in patients with major burns]." Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... 2001. PMID: 11518988 ↩

[49] Sun Y, Yan R, Yu D "[The relationship between severe burn injury and systemic inflammatory response syndrome]." Zhonghua wai ke za zhi [Chinese journal of surgery] 1998. PMID: 11715553 ↩

[50] Modi S, Rashid M, Malik A, Shahid M "Study of complement activation, C3 and interleukin-6 levels in burn patients and their role as prognostic markers." Indian journal of medical microbiology 2014. PMID: 24713898 ↩

[51] Lorente JA, et al. "Organ dysfunction as estimated by the sequential organ failure assessment score is related to outcome in critically ill burn patients." Shock (Augusta, Ga.) 2009. PMID: 18650779 ↩

[52] Gille J, Dietz A, Taha H, Sablotzki A "A sirs-based automated alarm system for the diagnosis of sepsis after burn injury." Annals of burns and fire disasters 2017. PMID: 29849519 ↩

[53] Yan J, Hill WF, Rehou S, Pinto R, Shahrokhi S, Jeschke MG "Sepsis criteria versus clinical diagnosis of sepsis in burn patients: A validation of current sepsis scores." Surgery 2018. PMID: 30049483 ↩

[54] Dalgic N, Sahin A, Karadag CA, Sancar M "Comparison of non-burn-specific systemic inflammatory response syndrome criteria and burn-specific American Burn Association systemic inflammatory response syndrome criteria in paediatric burned patients." Journal of paediatrics and child health 2020. PMID: 32841443 ↩

[55] Grieb G, Simons D, Piatkowski A, Bernhagen J, Steffens G, Pallua N "Macrophage migration inhibitory factor-A potential diagnostic tool in severe burn injuries?." Burns : journal of the International Society for Burn Injuries 2010. PMID: 19540674 ↩

[56] Lavrentieva A, et al. "Early coagulation disorders after severe burn injury: impact on mortality." Intensive care medicine 2008. PMID: 18193192 ↩

[57] Eljaiek R, Dubois MJ "Hypoalbuminemia in the first 24h of admission is associated with organ dysfunction in burned patients." Burns : journal of the International Society for Burn Injuries 2013. PMID: 22683139 ↩

[58] Li X, et al. "Perioperative lactate levels as prognostic indicators in patients undergoing early excision and grafting for extensive burns." BMC surgery 2025. PMID: 40887618 ↩

[59] Cerra FB, West M, Keller G, Mazuski J, Simmons RL "Hypermetabolism/organ failure: the role of the activated macrophage as a metabolic regulator." Progress in clinical and biological research 1988. PMID: 3289026 ↩

[60] Chai J, Sheng Z, Yang H "[Treatment of invasive burn wound infection with sepsis: a clinical study]." Zhonghua yi xue za zhi 1999. PMID: 11715506 ↩

[61] Malbrain ML, et al. "Intra-abdominal hypertension and abdominal compartment syndrome in burns, obesity, pregnancy, and general medicine." Anaesthesiology intensive therapy 2015. PMID: 25973659 ↩

[62] Jeschke MG, et al. "Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial." American journal of respiratory and critical care medicine 2010. PMID: 20395554 ↩

[63] Shields BA, et al. "The Interplay of Nutrition, Physical Activity, Severity of Illness, and Mortality in Critically Ill Burn Patients: Is There a Connection?." Journal of burn care & research : official publication of the American Burn Association 2019. PMID: 31298707 ↩

[64] Bingoel AS, et al. "Impact of different parameters on the outcome of vv-ECMO therapy in burn patients - a retrospective cohort study from a burn and high output ECMO center." Innovative surgical sciences 2025. PMID: 40778219 ↩

[65] Cooper AB, Cohn SM, Zhang HS, Hanna K, Stewart TE, Slutsky AS "Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score." Transfusion 2006. PMID: 16398734 ↩

[66] Linden K, et al. "Evaluation of the Cytosorb™ Hemoadsorptive Column in a Pig Model of Severe Smoke and Burn Injury." Shock (Augusta, Ga.) 2015. PMID: 26368927 ↩

[67] Endo S, Inada K, Sato N, Kawamura T "[Cytokines in surgical stress]." Nihon Geka Gakkai zasshi 1996. PMID: 8940680 ↩

[68] Struck MF, Reske AW, Schmidt T, Hilbert P, Steen M, Wrigge H "Respiratory functions of burn patients undergoing decompressive laparotomy due to secondary abdominal compartment syndrome." Burns : journal of the International Society for Burn Injuries 2014. PMID: 23790395 ↩

[69] Steinvall I, Fredrikson M, Bak Z, Sjoberg F "Incidence of early burn-induced effects on liver function as reflected by the plasma disappearance rate of indocyanine green: a prospective descriptive cohort study." Burns : journal of the International Society for Burn Injuries 2012. PMID: 22040928 ↩

[70] Albertson S, Greenhalgh DG, Breeden MP, Warden GD "Cardiac abnormalities in children with burns: an autopsy analysis." The Journal of burn care & rehabilitation 1994. PMID: 7995810 ↩

[71] De Saint-Victor JF, Durand G, Le Gulluche Y, Hoffmann JJ "[Neuropathies of septic syndrome with multiple organ failure in burnt patients: 2 cases with review of the literature]." Revue neurologique 1994. PMID: 7863155 ↩

[72] Williams FN, et al. "The leading causes of death after burn injury in a single pediatric burn center." Critical care (London, England) 2009. PMID: 19919684 ↩

[73] Swanson JW, et al. "Trajectories to death in patients with burn injury." The journal of trauma and acute care surgery 2013. PMID: 23271104 ↩

[74] Raffin TA "Intensive care unit survival of patients with systemic illness." The American review of respiratory disease 1989. PMID: 2669587 ↩

[75] Pastores SM, Katz DP, Kvetan V "Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome." The American journal of gastroenterology 1996. PMID: 8792684 ↩

[76] Xiao J, et al. "Increased survival rate in patients with massive burns." Burns : journal of the International Society for Burn Injuries 1992. PMID: 1445631 ↩

[77] Jeschke MG, et al. "Pathophysiologic Response to Burns in the Elderly." EBioMedicine 2015. PMID: 26629550 ↩

[78] Romanowski KS, Palmieri TL "Pediatric burn resuscitation: past, present, and future." Burns & trauma 2017. PMID: 28879205 ↩

[79] Santarelli MD, et al. "Persistent inflammation, immunosuppression, and catabolism syndrome and sepsis in pediatric burns." Burns : journal of the International Society for Burn Injuries 2025. PMID: 40555121 ↩

[80] Schweizer R, et al. "Risk Factors for Mortality and Prolonged Hospitalization in Electric Burn Injuries." Journal of burn care & research : official publication of the American Burn Association 2021. PMID: 33137191 ↩

[81] Dastagir K, et al. "Application of Critical Care Scores in Severely Burned Patients." Journal of burn care & research : official publication of the American Burn Association 2021. PMID: 33539518 ↩

[82] Su H, Yuan B, Liu Y, Xi W, Qiao L "Discriminative power of organ-specific SOFA assessment in burn sepsis: A temporal biomarker analysis." Burns : journal of the International Society for Burn Injuries 2026. PMID: 41297233 ↩

[83] Zhou YY, Wang Y, Wang L, Jiang H "The efficacy of Omega-3 polyunsaturated fatty acids for severe burn patients: A systematic review and trial sequential meta-analysis of randomized controlled trials." Clinical nutrition ESPEN 2024. PMID: 38220365 ↩